Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell

被引:179
作者
Peng-Zhang [1 ]
Dai, Ke-rong [2 ]
Yan, Shi-gui [1 ]
Yan, Wei-qi [1 ]
Chao-Zhang [4 ]
Chen, De-qiang [3 ]
Bo-Xu [3 ]
Xu, Zhan-wang [3 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed, Hangzhou 310009, Zhejiang, Peoples R China
[2] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai 200011, Peoples R China
[3] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Orthopaed, Jinan 250014, Shandong, Peoples R China
[4] Kun Hua Hosp, Kunming Med Coll, Dept Orthoped, Kunming 650032, Peoples R China
关键词
Naringin; Rhizoma drynariae; Osteogenic differentiation; Human bone mesenchymal stem cell; DRYNARIAE-RHIZOMA EXTRACTS; INHIBITION; MANAGEMENT; TISSUE;
D O I
10.1016/j.ejphar.2009.01.035
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Rhizoma drynariae is used commonly in the treatment of osteoporosis and bone nonunion in traditional Chinese medicine. Modern pharmacological research indicates that naringin is the main effective component of rhizoma drynariae, which can induce the expression of the osteogenic marker in the osteoblast cell line. However, no former study has described its effect on bone mesenchymal stem cells (BMSCs). In our experiment, we co-cultured human BMSCs with different concentrations of naringin solution, then the osteogenic differentiation markers and proliferation ability were analyzed. The results indicated that a certain concentration (1-100 mu g/ml) of the naringin solution may enhance the proliferation and osteogenic differentiation of human BMSCs. Also, our research explains excellently the anti-osteoporotic and bone nonunion treatment mechanism of rhizoma drynariae, thus contributing to the exploration of osteogenic differentiation agents from Chinese herbs. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 20 条
[1]
Berger I, 2007, HISTOL HISTOPATHOL, V22, P1231, DOI 10.14670/HH-22.1231
[2]
Ding Y, 1995, J Osaka Univ Dent Sch, V35, P21
[3]
The osteoblast: A sophisticated fibroblast under central surveillance [J].
Ducy, P ;
Schinke, T ;
Karsenty, G .
SCIENCE, 2000, 289 (5484) :1501-1504
[4]
Hamburger Matthias, 2007, Proc West Pharmacol Soc, V50, P156
[5]
Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells [J].
Jeong, JC ;
Lee, JW ;
Yoon, CH ;
Lee, YC ;
Chung, KH ;
Kim, MG ;
Kim, CH .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 96 (03) :489-495
[6]
Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts [J].
Jeong, JC ;
Kang, SK ;
Youn, CH ;
Jeong, CW ;
Kim, HM ;
Lee, YC ;
Chang, YC ;
Kim, CH .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (12) :1685-1697
[7]
Anabolic Agents: A New Chapter in the Management of Osteoporosis [J].
Khan, Abdul-Wahab ;
Khan, Aliya .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2006, 28 (02) :136-141
[8]
Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection [J].
Kou, Geng ;
Wang, Shuhui ;
Cheng, Changming ;
Gao, Jie ;
Li, Bohua ;
Wang, Hao ;
Qian, Weizhu ;
Hou, Sheng ;
Zhang, Dapeng ;
Dai, Jianxin ;
Gu, Hongchen ;
Guo, Yajun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 374 (02) :192-197
[9]
A review of anabolic therapies for osteoporosis [J].
Lane, NE ;
Kelman, A .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (05) :214-222
[10]
The effect of the major components of Salvia Miltiorrhiza Bunge on bone marrow cells [J].
Liu, Y. R. ;
Qu, S. X. ;
Maitz, M. F. ;
Tan, R. ;
Weng, J. .
JOURNAL OF ETHNOPHARMACOLOGY, 2007, 111 (03) :573-583